Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-05 Sale | 2025-05-05 9:54 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 1,784 | $21.05 | $37,553 | 98,046 (Direct) | View |
| 2025-05-05 Sale | 2025-05-05 9:53 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 18,924 | $21.05 | $398,350 | 438,097 (Direct) | View |
| 2025-05-05 Sale | 2025-05-05 9:53 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 1,771 | $21.05 | $37,280 | 133,135 (Direct) | View |
| 2025-05-05 Sale | 2025-05-05 9:52 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 3,198 | $21.05 | $67,318 | 105,161 (Direct) | View |
| 2025-05-05 Sale | 2025-05-05 9:51 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 4,920 | $21.05 | $103,566 | 94,402 (Direct) | View |
| 2025-04-11 Sale | 2025-04-14 6:23 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 48 | $13.14 | $631 | 89,990 (Direct) | View |
| 2025-02-12 Sale | 2025-02-12 9:30 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 5,200 | $23.53 | $122,356 | 98,519 (Direct) | View |
| 2025-02-12 Sale | 2025-02-12 9:28 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 8,000 | $23.53 | $188,240 | 89,482 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 9:27 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 54,244 | $25 | $1,356,100 | 54,410 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 9:25 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 5,642 | $24.33 | $137,276 | 125,066 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 9:23 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 11,375 | $24.04 | $273,455 | 419,173 (Direct) | View |
| 2025-02-12 Sale | 2025-02-12 9:22 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,568 | $23.53 | $60,426 | 89,602 (Direct) | View |
| 2025-02-06 Sale | 2025-02-10 6:04 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $22 | $220,000 | 31,000 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 8,951 | $19.78 | $177,051 | 153,719 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 8,951 | $19.78 | $177,051 | 147,482 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 50,691 | $20.21 | $1,024,343 | 690,548 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 5,273 | $20.12 | $106,082 | 184,170 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 5,166 | $20.12 | $103,940 | 180,708 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 5,192 | $20.12 | $104,463 | 148,038 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 3,348 | $20.12 | $67,362 | 89,654 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 8:40 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 2,437 | $19.46 | $47,424 | 83,170 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 8:39 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 10,736 | $19.46 | $208,923 | 351,239 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 8:37 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 2,437 | $19.46 | $47,424 | 76,933 (Direct) | View |
| 2025-01-23 Sale | 2025-01-23 8:36 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $20 | $320,000 | 31,000 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 8:35 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 1,584 | $18.94 | $30,002 | 106,374 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 8:33 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 865 | $18.94 | $16,384 | 73,730 (Direct) | View |
| 2025-01-22 Sale | 2025-01-23 8:31 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 925 | $18.94 | $17,520 | 54,002 (Direct) | View |
| 2025-01-03 Sale | 2025-01-06 7:21 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,506 | $19.04 | $47,715 | 59,443 (Direct) | View |
| 2024-12-26 Sale | 2024-12-27 7:47 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $17.22 | $258,277 | 54,927 (Direct) | View |
| 2024-11-25 Sale | 2024-11-25 9:00 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 12,090 | $18.3 | $221,258 | 69,927 (Direct) | View |
| 2024-10-04 Sale | 2024-10-04 7:15 pm | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 40,000 | $14.73 | $589,101 | 51,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Williams Brinkley Ruth Director | 26,000 | $0 | 45,250 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Squarer Ron Director | 26,000 | $0 | 54,875 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Poole Sandra Director | 26,000 | $0 | 49,500 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 26,000 | $0 | 54,875 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 26,000 | $0 | 107,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 26,000 | $0 | 77,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director | 26,000 | $0 | 75,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director | 26,000 | $0 | 48,250 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 26,000 | $0 | 57,000 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-05 9:54 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 4,920 | $0 | 98,046 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-05 9:53 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 18,924 | $0 | 438,097 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-05 9:53 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 4,920 | $0 | 133,135 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-05 9:52 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Chief Research Officer | 4,920 | $0 | 105,161 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-05 9:51 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E Chief Legal Officer and GC | 4,920 | $0 | 94,402 (Direct) | View |
| 2025-02-10 Exercise | 2025-02-12 9:30 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 8,000 | $0 | 98,519 (Direct) | View |
| 2025-02-10 Exercise | 2025-02-12 9:28 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 8,000 | $0 | 89,482 (Direct) | View |
| 2025-02-11 Exercise | 2025-02-12 9:27 pm | N/A 2026-05-19 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 45,000 | $0 | 54,410 (Direct) | View |
| 2025-02-11 Exercise | 2025-02-12 9:27 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 10,000 | $17.44 | 54,410 (Direct) | View |
| 2025-02-11 Exercise | 2025-02-12 9:27 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $15.46 | 54,410 (Direct) | View |
| 2025-02-11 Exercise | 2025-02-12 9:27 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 10,000 | $17.96 | 54,410 (Direct) | View |
| 2025-02-11 Exercise | 2025-02-12 9:27 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 10,000 | $16.23 | 54,410 (Direct) | View |
| 2025-02-10 Exercise | 2025-02-12 9:25 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 8,000 | $0 | 125,066 (Direct) | View |
| 2025-02-10 Exercise | 2025-02-12 9:22 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 8,000 | $0 | 89,602 (Direct) | View |
| 2025-02-06 Exercise | 2025-02-10 6:04 pm | N/A 2027-05-17 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $0 | 31,000 (Direct) | View |
| 2025-02-06 Exercise | 2025-02-10 6:04 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $17.44 | 31,000 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 79,500 | $0 | 153,719 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 79,500 | $0 | 147,482 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 390,000 | $0 | 690,548 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 130,000 | $0 | 184,170 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 79,500 | $0 | 180,708 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 79,500 | $0 | 148,038 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 39,000 | $0 | 89,654 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-23 8:36 pm | N/A 2026-07-19 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $0 | 31,000 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-23 8:36 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $17.5 | 31,000 (Direct) | View |
| 2024-12-26 Exercise | 2024-12-27 7:47 pm | N/A 2025-01-02 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $0 | 54,927 (Direct) | View |
| 2024-12-26 Exercise | 2024-12-27 7:47 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $12.67 | 54,927 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-25 9:00 pm | N/A 2025-01-02 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $0 | 69,927 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-25 9:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $12.67 | 69,927 (Direct) | View |
| 2024-10-04 Exercise | 2024-10-04 7:15 pm | N/A 2024-10-08 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 40,000 | $0 | 51,000 (Direct) | View |
| 2024-10-04 Exercise | 2024-10-04 7:15 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 40,000 | $10.48 | 51,000 (Direct) | View |